[Table/Fig-5]:

Percentage data of non-hematological adverse events

Adverse event	Intaxel Group					Taxol Group
	CTC Grade					CTC Grade
	Grade 1	Grade 2	Grade 3	Grade 4	Total	Grade 1	Grade 2	Grade 3	Grade 4	Total
Alopecia	2	8	2	3	15 (60%)	1	17	1	2	21 (88%)
Asthenia	2	4			6 (24%)	8	3			11 (46%)
Neurosensory loss		1			1 (4%)	5	3			8 (33%)
Nausea	5				5 (20%)	3	3			6 (25%)
Vomiting		1	1		2 (8%)		3			3 (13%)
Myalgia	1				1 (4%)	2	3			5 (21%)
Pain in limbs	1	1			2 (8%)	1	1			2 (8%)
Diarrhoea	1	1	1		3 (12%)	1				1 (4%)
Cough		1			1 (4%)		1			1 (4%)
Fever					-	3				3 (13%)
Loss of appetite					-	2	1			3 (13%)
Headache					-		2			2 (8%)
Abdominal pain					-	1	1			2 (8%)
Motor Neuropathy					-		1			1 (4%)
Nail changes					-	1				1 (4%)
Hypersensitivity					-		1			1 (4%)
Urticaria					-	1				1 (4%)
Skin hyperemia					-		1			1 (4%)
Flushing	1				1 (4%)					-
Nail pain	1				1 (4%)					-
Bone pain	1				1 (4%)					-
Tachycardia	1				1 (4%)					-
Epistaxis	1				1 (4%)					-
Epigastric pain		1			1 (4%)					-
Somnolence		1			1 (4%)					-
Conjunctivitis					-	1				1 (4%)
Superficial phlebitis					-		1			1 (4%)
Lymphedema					-		1			1 (4%)
Aphthous ulcer					-		1			1 (4%)
Sacral abscess					-		1			1 (4%)
Loss of consciousness					-		1			1 (4%)